【Clinical Trials Sponsored by JMTO】The Japan-Multinational Trial Organization -JMTO-

Study ID	CTR ID	Official scientific title of the study	Condition	Progress	Publication of Results	Protocol	Funding Souce
JMTO LC 12-01	UMIN 000007765	A randomized phase II trial of docetaxel or pemetrexed with or without gefitinib in elderly advanced non-small cell lung cancer patients harboring activating EGFR mutation after failure of the therapy as first-line treatment.	Non-small cell lung cancer	Open public recruiting	Unpublised		Astra Zeneca
JMTO LC 09-01	UMIN 000001826	Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)	Non-small cell lung cancer	No longer recruiting	Unpublised
JMTO LC 08-01	UMIN 000001246	Randomized phase II trial comparing amrubicine/irinotecan with cisplatin/irinotecan in patients with extensive-stage small-cell lung cancer: (JMTO LC 08-01)	Small cell lung cancer	No longer recruiting	Unpublised
JMTO PCa10-01	UMIN 000004096	A study to evaluate efficacy and safety of docetaxel combined with dexamethasone in patients with hormone refractory prostate cancer ; JMTO PCa10-01	Prostate cancer	No longer recruiting	Unpublised
JMTO PREV 07-01	UMIN 000000776 NCT 00508690	Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics	Colorectal tumor with planned elective laparoscopic resection	No longer recruiting	Unpublised	ver150109
Study ID	CTR ID	Official scientific title of the study	Condition	Progress	Publication of Results	Protocol	Funding Souce
JMTO BC 08-01	UMIN 000001217	Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phaseⅡtrial.	Breast cancer	Completed	Publised Oncology Reports 2013;29:1707-1713
JMTO LC 07-02	UMIN 000001280	A feasibility study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in evaluation of mediastinal nodal metastasis of lung cancer	Lung cancer	No longer recruiting	Unpublised
JMTO LC 07-01	UMIN 000001225	Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.	Non-small cell lung cancer	Completed	Publised Anticancer Research 2013 ; 33 : 4631-4637
JMTO LC 05-01	UMIN 000001271	Prognostic factors after complete resection of pN2 non-small cell lung cancer.	Non-small cell lung cancer	Completed	Publised Journal of Thoracic and Cardiovascular Surgery 2013; 146 : 788-795
JMTO LC 03-03		A phase I study of amrubicin (AMR) and fixed-dose of irinotecan (CPT-11) in relapsed small cell lung cancer (SCLC) -Japan Multinational Trial Organization (JMTO) LC0303.	relapsed small cell lung cancer (SCLC)	Completed	Publised Journal of Thoracic Oncology　2012;7:1845-1849
Study ID	CTR ID	Official scientific title of the study	Condition	Progress	Publication of Results	Protocol	Funding Souce
JMTO LC 03-02		Interstitial lung disease in gefitinib treated Japanese patients with non-small cell lung cancer －a retrospective analysis : JMTO LC03-02.	Non-small cell lung cancer	Completed	Publised BMC Research Notes 2009;2:157
JMTO LC 02-02		A Weekly combination of carboplatin and irinotecan for previously untreated extensive disease small cell lung cancer, results of minimum follow-up of 3 years : A multi-center phase II trial JMTO LC02-02.	Small cell lung cancer	Completed	Publised Japanese Journal of Clinical Oncology　2012;42:387-393
JMTO BC 02-01		Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.	Breast cancer	Completed	Publised Anti-Cancer Drugs 2008;19:911-915
JMTO LC 00-04		Non-Small Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics. Journal of Clinical Oncology 2009;21:3540-3546 Serum osteopontin levels are highly prognostic for survival in advanced non-small-cell lung cancer: results from JMTO-LC0004. Journal of Thoracic Oncology 2009;4:1104-1110	Non-small cell lung cancer	Completed	Publised Journal of Clinical Oncology 2009;21:3540-3546 Journal of Thoracic Oncology 2009;4:1104-1110
JMTO LC 00-03		Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phaseⅢ study. Lancet Oncology 2008;9:1135-42	Non-small cell lung cancer	Completed	Publised Lancet Oncology 2008;9:1135-1142 European Journal of Cancer 2009;45:1950-1958. British Journal of Cancer 2009;101:1537-1542.
Study ID	CTR ID	Official scientific title of the study	Condition	Progress	Publication of Results	Protocol	Funding Souce
JMTO LC 00-02		Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer : a multi-institutional phase Ⅱ trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).	Non-small cell lung cancer	Completed	Publised British Journal of Cancer 2003;88:342-347
JMTO LC 00-01		A feasibility study of paclitaxel 225 mg/m2 and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in Japan.	Non-small cell lung cancer	Completed	Publised Japanese Journal of Clinical Oncology 2002;32:48-53
JMTO OC 01-01		The impact of therapeutic modalities on the outcome of advanced epithelial ovarian cancer patients treated in Japan. A JMTO study. J Clin Oncol 22:473s,2004. A new prognostic index of advanced epithelial ovarian cancer (PIEPOC): A JMTO OC01-01 study. Proc ASCO 2006 (abstract #5061)	Ovarian cancer	Completed	Publised J Clin Oncol 22:473s,2004. Proc ASCO 2006 (abstract #5061)

　Top